Position in IMVT
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$18,542,910
+$2,148,053 QoQ
Shares Held
746,494
+15.7% QoQ
Ownership
0.364%
of shares outstanding
% of Portfolio
3.55%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 88.19012610951998.ToString("F0")%
Shared 0.ToString("F0")%
None 11.80987389048003.ToString("F0")%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Derivatives in IMVT
reported options exposure · as of Mar 31, 2026CallValue
$2,484,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026STEMPOINT CAPITAL LP holds $493,288,963 across 62 Biotechnology names. IMVT ranks #5 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
1,035,496 | $50,904,983 | |
| 2 | ABVX |
Abivax S.A.
|
313,791 | $34,940,627 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
1,215,743 | $28,399,756 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
281,632 | $27,388,712 | |
| 5 | IMVT |
Immunovant, Inc.
This page
|
746,494 | $18,542,910 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
56,267 | $18,128,664 | |
| 7 | SRZN |
Surrozen, Inc./DE
|
525,639 | $15,311,863 | |
| 8 | MBX |
MBX Biosciences, Inc.
|
499,469 | $14,909,149 |
All Filings in IMVT
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,484,000 | 100,000 | Call | Sole | 2026-05-18 | |
| 2026-03-31 | $18,542,910 | 746,494 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $16,394,857 | 644,959 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,624,029 | 1,589,580 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $4,030,000 | 250,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $1,600,000 | 100,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $20,813,760 | 1,300,860 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,585,836 | 853,472 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $27,705,443 | 1,118,508 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,130,238 | 671,001 | Shares | Sole | 2024-11-13 | |
| 2024-09-30 | $5,702,000 | 200,000 | Call | Sole | 2024-11-13 | |
| 2024-06-30 | $26,713,605 | 1,011,879 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,077,500 | 250,000 | Call | Sole | 2024-08-09 | |
| 2024-03-31 | $20,265,736 | 627,228 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $13,566,491 | 322,015 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||